Ingalls & Snyder LLC’s Mesoblast MESO Stock Holding History

Ingalls & Snyder LLC’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,000	Closed	-$53K	–	425
2020 Q1	$53K	Buy	+6,000	New	+$92K	﹤0.01%	397

Other funds holding MESO

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

OAMG

Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Ingalls & Snyder LLC's MESO Position: Q2 2020 in Review

Ingalls & Snyder LLC sold out of Mesoblast (MESO) in Q2 2020, closing a stake of 6,000 shares — an estimated $53K sold.

Ingalls & Snyder LLC first reported a position in MESO in Q1 2020 and held it in 1 quarter. The position peaked at $53K in Q1 2020. 43 funds tracked by Wall St. Rank hold MESO as of Q2 2020.

Ingalls & Snyder LLC reported no remaining Mesoblast position as of Q2 2020 after selling out during the quarter.
Ingalls & Snyder LLC sold 6,000 Mesoblast shares in Q2 2020, an estimated $53K.
Ingalls & Snyder LLC first reported a position in Mesoblast in Q1 2020 and held it in 1 quarter.
Ingalls & Snyder LLC's Mesoblast position peaked at $53K in Q1 2020.
43 funds tracked by Wall St. Rank held Mesoblast as of Q2 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2020, filed 31 Jul 2020.